On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Tissue engineering
- Historical perspective
- The culture of organs
- Biomedical devices and diagnostics industry: 2002
- Medical implant industry
- Tissue engineering and the implant industry
- Spare body parts
- Approved tissue products
- DERMAGRAFT on traumatic wounds
- Tissue engineered skin substitutes
- 8th annual hilton head workshop panel discussion
- Off-the-shelf availability
- Cell source can be a "show stopper"
- Use of autogous cells
- Use of allogeneic cells
- Embryonic stem cells
- "Flavors" of pluripotency exist
- Differentiation of embryonic stem cells
- Bone marrow-derived cells
- Scaffold strategies
- The matrix and cell function
- Cells in 2D configuration versus 3D configuration
- Bioreactor technology (1)
- Bioreactor technology (2)
- In vivo versus the in vitro bioreactor
- Development of a cell-seeded scaffold
- Integration into the living systems
- Some tissue engineering applications
- Combination products
- Therapeutic products
- What are some of the issues?
- Testing really begins after FDA approval
- Key industry trends since 2000
- Problems encountered by companies
- Advanced tissue sciences: a case study
- Status of industry: 2006
- Medtronic, inc.
- MG biotherapeutics
- Tissue engineering 2006
- Some research challenges
- Advances envisioned
- The industry of the future
Topics Covered
- Historical perspective
- Biomedical devices and diagnostics industry
- Medical implant industry
- Approved tissue products
- Dermagraft
- Tissue engineered skin substitutes
- Cell source
- Matrix
- Immune tolerance
- Off-the-shelf availability
- Embryonic stem cells
- Scaffolds
- Bioreactor technology
- Integration into the living system
- Therapeutic products
- Key industry trends
- Advances envisioned
Talk Citation
Nerem, R. (2007, October 1). Tissue engineering: the science, the technology and the industry [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 17, 2025, from https://doi.org/10.69645/CPCC1093.Export Citation (RIS)
Publication History
- Published on October 1, 2007
Financial Disclosures
- Prof. Robert Nerem has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Tissue engineering: the science, the technology and the industry
Published on October 1, 2007
27 min